CIK 0001585608
- Non-accelerated filer
- Smaller reporting company
Jaguar Health, Inc.
Sign in to watch- Ticker
- JAGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-371-8300
- Business address
- 200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
- Former names
- Jaguar Animal Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-11 | MICEK JOHN Director | Grant or award | +7,377 | 7,430 | ||
| 2025-12-11 | MICEK JOHN Director | Grant or award · Stock Option (right to buy) | +7,377 | 7,377 | ||
| 2025-12-11 | King Steven R. See Remarks | Grant or award | +11,740 | 11,885 | ||
| 2025-12-11 | King Steven R. See Remarks | Grant or award · Stock Option (right to buy) | +11,740 | 11,740 | ||
| 2025-12-11 | Wolin Jonathan S. See Remarks | Grant or award | +11,740 | 11,938 | ||
| 2025-12-11 | Wolin Jonathan S. See Remarks | Grant or award · Stock Option (right to buy) | +11,740 | 11,740 | ||
| 2025-12-11 | CONTE LISA A See Remarks | Grant or award | +28,592 | 29,258 | ||
| 2025-12-11 | CONTE LISA A See Remarks | Grant or award · Stock Option (right to buy) | +28,592 | 28,592 | ||
| 2025-12-11 | Chaturvedi Pravin R Chief Scientific Officer | Grant or award | +11,740 | 11,938 | ||
| 2025-12-11 | Chaturvedi Pravin R Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +11,740 | 11,740 | ||
| 2025-12-11 | BOCHNOWSKI JAMES J Director | Grant or award | +6,363 | 6,415 | ||
| 2025-12-11 | BOCHNOWSKI JAMES J Director | Grant or award · Stock Option (right to buy) | +6,363 | 6,363 | ||
| 2025-12-11 | Siegel Jonathan B. Director | Grant or award | +7,377 | 7,423 | ||
| 2025-12-11 | Siegel Jonathan B. Director | Grant or award · Stock Option (right to buy) | +7,377 | 7,377 | ||
| 2025-12-11 | Jayasuriya Anula Director | Grant or award | +5,870 | 5,916 | ||
| 2025-12-11 | Jayasuriya Anula Director | Grant or award · Stock Option (right to buy) | +5,870 | 5,870 | ||
| 2025-12-11 | Lizak Carol R. Chief Financial Officer | Grant or award | +11,740 | 11,911 | ||
| 2025-12-11 | Lizak Carol R. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +11,740 | 11,740 | ||
| 2025-06-24 | Siegel Jonathan B. Director | Returned to the company · Convertible Promissory Note | −9,000 | $50,000.00 | $450.0M | 0 |
| 2025-06-24 | Siegel Jonathan B. Director | Grant or award · Convertible Promissory Note | +9,462 | $50,000.00 | $473.1M | 9,462 |
Page 1 of 10 · 185 trades